Hard agree, and not just because I'm a spreadsheet nerd. Why are we all here? Isn't it in the service…
Morning Headlines 11/5/21
Allscripts Announces Third Quarter 2021 Results
Allscripts announces Q3 results: revenue up 1%, adjusted EPS $0.27 versus $0.11.
Aver Raises $58 Million Investment led by Cox Enterprises and Introduces New Name, Enlace Health
Claims-based analytics vendor Aver raises $58 million and rebrands to Enlace Health to better reflect its focus on solving “the infrastructure challenges driving today’s unsustainable healthcare system.”
Change Healthcare Inc. Reports Second Quarter Fiscal 2022 Financial Results
Change Healthcare reports Q2 results: revenue up 9%, EPS –$0.11 versus –$0.13, beating earnings expectations but falling short on revenue.
What is interesting about the Allscripts Q3 results is the that they are reporting 3 months ending December 31st 2020 vs the same period 2019 and not through Q3 of 2021 (take a look at tables 1-5).
I wonder if they addressed the voluntary quit velocity in the call — rumors are it is in the 20-30% range.
I think that’s b/c those numbers compare financials when they had CarePort and EPSI—so apples-to-apples. Stock up 7% this morning, guess Wall Street likes the positive cash flow.
ECW is done, no group of size will consider them given their history with the ONC and DOJ. Ambulatory is a three headed race: NextGen, Allscripts, and Athena. And if you don’t want to outsource your billing and/or you want complete control over your data then Athena is out and it’s a two-headed race: Allscripts and NextGen.
Yes, smaller market has a lot more competitors.
Yes, when part of a hospital those deals automatically go to Epic/Cerner/Meditech/Allscripts.
NextGen and Allscripts sitting pretty with cash, decades of data, and way less comp then three years ago.